Thus, the level of XOR expression may also be a prognostic factor for the clinical outcomes of colorectal carcinomas, suggesting a neoplasia suppressor role for XOR in this tumor, as well as in breast and gastric cancers 43. This evidence concerns the gene XDH and neoplasm.